PMVP (PMV Pharmaceuticals, Inc.) Stock Financials & Earnings | Market Cap Arena

PMVP (PMV Pharmaceuticals, Inc.) Stock Financials & Earnings | Market Cap Arena

PMVPPMV Pharmaceuticals, Inc.

Mkt Cap$88M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$83M

EPS (TTM)-$0.78

Free Cash Flow (TTM)-$73M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 22	$0	$0	-$21M
Q1 23	$0	$0	-$21M
Q2 23	$0	$0	-$20M
Q3 23	$0	$0	-$20M
Q4 23	$0	-$359K	-$19M
Q1 24	$0	-$362K	-$18M
Q2 24	$0	-$372K	-$20M
Q3 24	$0	$0	-$22M
Q4 24	$0	$0	-$25M
Q1 25	$0	$0	-$22M
Q2 25	$0	-$32K	-$23M
Q3 25	$0	-$32K	-$23M

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 22	-$15M	-$17M
Q1 23	-$15M	-$15M
Q2 23	-$13M	-$13M
Q3 23	-$16M	-$16M
Q4 23	-$12M	-$12M
Q1 24	-$16M	-$17M
Q2 24	-$2M	-$2M
Q3 24	-$17M	-$17M
Q4 24	-$17M	-$17M
Q1 25	-$18M	-$18M
Q2 25	-$18M	-$18M
Q3 25	-$20M	-$20M

Capital Expenditures

CapEx

Quarter	CapEx
Q4 22	$2M
Q1 23	$156K
Q2 23	$565K
Q3 23	$44K
Q4 23	$197K
Q1 24	$594K
Q2 24	$4K
Q3 24	$1K
Q4 24	$56K
Q1 25	$4K
Q2 25	$11K
Q3 25	$1K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 22	—	+14.6%
Q1 23	—	+15.4%
Q2 23	—	+12.5%
Q3 23	—	+1.3%
Q4 23	—	-10.7%
Q1 24	—	-15.2%
Q2 24	—	+0.2%
Q3 24	—	+11.5%
Q4 24	—	+33.1%
Q1 25	—	+18.3%
Q2 25	—	+13.4%
Q3 25	—	+2.9%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 22	$0	—
Q1 23	$0	—
Q2 23	$3M	—
Q3 23	$3M	—
Q4 23	$3M	—
Q1 24	$3M	—
Q2 24	$3M	—
Q3 24	$2M	—
Q4 24	$1M	—
Q1 25	$2M	—
Q2 25	$2M	—
Q3 25	$0	—

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q4 22	$15M	$6M	—
Q1 23	$15M	$6M	—
Q2 23	$14M	$6M	—
Q3 23	$14M	$6M	—
Q4 23	$13M	—	$6M
Q1 24	$13M	$5M	—
Q2 24	$14M	$6M	—
Q3 24	$17M	$5M	—
Q4 24	$14M	$11M	—
Q1 25	$17M	$4M	—
Q2 25	$18M	$4M	—
Q3 25	$18M	—	$4M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$143M	$86M	$229M
Q2 23	$68M	$119M	$187M
Q3 23	$52M	$150M	$202M
Q4 23	$38M	$165M	$203M
Q1 24	$48M	$150M	$198M
Q2 24	$49M	$164M	$213M
Q3 24	$49M	$134M	$183M
Q4 24	$41M	$129M	$169M
Q1 25	$51M	$109M	$160M
Q2 25	$44M	$98M	$142M
Q3 25	$36M	$93M	$129M
Q4 25	$38M	$75M	$113M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q4 22	46M	+0.2%
Q1 23	46M	+0.2%
Q2 23	46M	+0.1%
Q3 23	49M	+7.1%
Q4 23	51M	+4.9%
Q1 24	51M	+0.0%
Q2 24	51M	+0.1%
Q3 24	52M	+0.2%
Q4 24	52M	+0.0%
Q1 25	52M	+0.7%
Q2 25	52M	+0.1%
Q3 25	53M	+1.9%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 18	—	—
FY 19	—	—
FY 20	$0	44
FY 21	$0	54
FY 22	$0	62
FY 23	$0	63
FY 24	$0	47
FY 25	$0	200K